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Background: Multiple sclerosis (MS) patients suffer from various difficulties including 
sleep complaints, symptoms of depression and fatigue, paresthesia, and cognitive 
impairments. There is growing evidence that regular physical activity has a positive effect 
on both sleep and psychological functioning, though there is limited evidence of this kind 
for MS patients. The aim of the present study was therefore to investigate the impact on 
this patient group of a regular exercise program with respect to subjective and objective 
sleep, depression, paresthesia, fatigue, and cognitive performance.
Methods: A total of 46 patients [mean age: 50.74 years; Expanded Disability Status 
Scale (EDSS): mean: 5.3, 78.4% females] completed this 3-week intervention study. At 
baseline and 3 weeks later, they answered questionnaires covering sociodemographic 
information, subjective sleep, depression, fatigue, paresthesia, and subjective physical 
activity. Objective sleep [sleep electroencephalogram (EEG) recordings] and cognitive 
performance were also assessed at both time points. Patients participated in a regular 
exercise activity every weekday for about 60 min.
Results: Compared to the baseline, by the end of the study, objective sleep had 
significantly improved (sleep efficiency, sleep onset latency, and wake time after sleep 
onset), and symptoms of sleep complaints, depression, fatigue, and paresthesia were 
significantly reduced. Subjective physical activity (moderate and vigorous) and cognitive 
performance also increased over the course of the intervention.
Conclusions: In patients with MS, participation in regular exercise impacted positively on their 
objective and subjective sleep, depression, paresthesia, fatigue, and cognitive performance.
Keywords: cognitive performance, exercise, rehabilitation, multiple sclerosis, physical activity intervention, sleep-
EEG, sleep
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INTRODUCTION
Worldwide, about 2.5 million people suffer from multiple sclerosis 
(MS) (1). Multiple sclerosis (MS) is defined as a neurodegenerative 
disease involving both psychological and physical impairments 
(2). Typically, MS sufferers have sleep complaints, symptoms 
of depression, fatigue, and paresthesia (3–8), reduced physical 
activity levels (9–13), and cognitive impairments (14–17). 
Importantly, Carta et al. (18) and Fornaro et al. (19) underlined 
the importance of a thorough pharmacological treatment of 
psychiatric symptoms in individuals with MS. With regard to 
sleep, recent research has shown that at MS onset, sleep is not 
impaired (20). The same research group also found that sleep 
quality in these patients remained unchanged 2 years after disease 
onset (21). Not surprising, poor sleep, symptoms of depression, 
paresthesia, fatigue, and cognitive impairments have a negative 
impact on quality of life (22, 23). It follows therefore that their 
improvements should have a beneficial effect on patients’ quality 
of life (24–26). There are various treatment options for improving 
attributes such as sleep and cognitive performance and reducing 
depression and fatigue, among MS patients, and given that 
these psychological and physical characteristics appear to be 
highly interlinked, one might expect that their improvements 
or impairments would also be associated with improvements or 
impairments in the others (27–31).
With regard to sleep, numerous studies of otherwise healthy 
individuals have shown poor sleep to be associated with poor 
emotion regulation (32–34), lower cognitive performance (35, 
36), and mood alterations (37, 38). Among MS patients, poor 
sleep has been linked to impaired cognitive performance (28, 
31), higher fatigue scores, and depression (27, 39, 40). Several 
reviews also conclude that sleep is impaired in about 50% of MS 
patients (3, 4, 6–8, 29, 41–43). However, Sadeghi Bahmani et  al. 
(20) showed  that, among a small sample of MS patients aged 
32.3  years, sleep quality indices at disease onset did not differ 
from the indices of nonclinical adolescents and young adults. It 
is notable that in the same group of patients, sleep quality indices 
were no different 2 years later (21), though sedentary behavior 
had decreased and levels of moderate physical activity increased, 
but vigorous physical activity had decreased.
There are several potential treatment options for improving 
the sleep of MS patients. Pharmacological interventions mainly 
consist of the prescription of benzodiazepines and selective 
serotonin reuptake inhibitors (SSRIs), although their long-term 
efficacy appears to be questionable. Furthermore, their side 
effects can be irritating and may even increase daytime sleepiness, 
depression, and fatigue, and worsen cognitive performance (3, 
44, 45); for these reasons, they are not suitable for long-term 
treatment. Nonpharmacological treatment approaches include 
cognitive behavioral therapy (46, 47) and relaxation techniques 
(43, 48–50). Several studies of healthy individuals have also shown 
that exercise interventions can improve sleep (51–55). However, 
there are only a few studies on the benefits of interventions for 
MS patients. As one example, Siengsukon et al. (56) randomly 
allocated 28 MS patients either to moderate-intensive aerobic 
exercise or to low-intensive walking/stretching. Patients engaged 
in one or other of these activities for 30 min three times a week, 
and for consecutive 12 weeks. Outcome variables were sleep 
quality, daytime sleepiness, fatigue, and depression. Results 
showed that sleep quality improved descriptively from baseline 
to postintervention. Nevertheless, a significant improvement in 
sleep was only observed in the low-intensity walking/stretching 
condition, whereas daytime sleepiness improved only in the 
moderate-intensity aerobic exercise condition. Interestingly, 
improvements in sleep and daytime sleepiness were not associated 
with any changes in depression or fatigue. To conclude, given the 
paucity of research into physical activity interventions to improve 
sleep among patients with MS, the first aim of the present study 
was to examine whether an intervention involving regular 
exercise could improve both objective and subjective sleep.
Additionally, there is a growing body of research showing 
that regular physical activity has a positive impact on fatigue, 
depression, and, for example, cardiovascular fitness in MS 
patients (10–12, 24, 57–63). In this regard, De Berardis et al. 
(64), Marini et al. (65), and Lang and Borgwardt (66) showed 
associations between symptoms of major depressive disorder and 
inflammatory markers.
With regard to paresthesia, to our knowledge, Razazian et al. 
(67) were first to show that regular physical activity (yoga and 
aquatic exercise) could reduce paresthesia, although indirectly 
via reductions in depression. Therefore, the second aim of 
the present study was to determine whether regular exercise 
would also have a positive impact on depression, fatigue, and 
paresthesia. Accordingly, the endpoints were as follows: Changes 
in objective and subjective sleep, depression, fatigue, and 
paresthesia. Secondary endpoint variables were physical activity 
and cognitive function.
Four hypotheses were formulated. First, following others (51, 
52, 54), we expected that the objective sleep of MS patients would 
improve over 3 weeks of regular exercise. Second, following 
Siengsukon et al. (56), we anticipated that 3 weeks of regular exercise 
would improve their subjective sleep. Third, following others (10, 
24, 57, 58, 67, 68), we hypothesized that 3 weeks of regular exercise 
would have a positive impact on depression, fatigue, and paresthesia 
among such patients. Fourth, in line with previous research (69–
71), we expected that a 3-week program of regular exercise would 
improve the cognitive performance of MS patients.
METHODS
Procedure
In the present study, inpatients with MS of the Klinik Valens 
(a rehabilitation center located in the Southeastern part of 
Switzerland) were approached and asked to participate in the 
present 3-week intervention study (a 3-week stay was the fixed 
duration of hospitalization in the clinic based on the insurance 
system in Switzerland). All participants were informed about the 
voluntary character of their participation and were assured that 
all the data were gathered anonymously. Signed written informed 
consent was obtained from the participants. All assessments took 
place both at baseline and 3 weeks later at discharge. At both time 
points, participants completed a series of questionnaires covering 
sociodemographic data, sleep complaints, depression, fatigue, 
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paresthesia, and physical activity (see Tools below). Completion 
of the questionnaire took 30–40 min. A trained expert assessed 
participants’ cognitive performance and applied the EEG device 
for sleep assessment during one night at baseline and study end.
The local ethics committees of Basel (Ethikkommission 
Nordwestschweiz; EKNZ: 2016-01347) and St. Gallen (EKOS; 
Switzerland) approved the study, which was carried out 
in accordance with the ethical principles laid down in the 
Declaration of Helsinki and its later amendments.
Participants
Fifty-one patients were consecutively selected. Details of their 
EDSS scores and disease duration data were extracted from 
the Klinik Valens registered data. Inclusion criteria were as 
follows: a) physician-determined diagnosis of MS (following 
the McDonalds’ diagnostic criteria for MS) (72) irrespective of 
subtype (relapse–remitting, primary progressive, and secondary 
progressive), b) neurologist-rated EDSS score below 6.0, c) age 
between 18 and 65 years, d) willing and able to comply with 
the study requirements as attested by signed written informed 
consent, e) able to read and write in German, and f) stable 
MS-related pharmacological treatment such as glatiramer acetate, 
interferons, fumarates and immune suppressiva, and monoclonal 
antibodies at the beginning of the study and throughout the whole 
study. Exclusion criteria were as follows: a) other neurological or 
severe psychiatric disorders and b) intake of medications apart 
from MS-related medications and antidepressants.
MEASURES
Objective Sleep
As in previous studies (73–77), we assessed objective sleep first 
for one night at baseline and then for one night at the end of the 
study using a one-channel, portable sleep-EEG recording device. 
Its validity has been repeatedly confirmed (77). The following 
sleep continuity parameters were measured: sleep onset latency, 
sleep period time, total sleep time, and number and time of 
awakenings after sleep onset. The following sleep architecture 
parameters were measured: awakenings after sleep onset (number 
and duration in minutes); (non-REM sleep) stages 1 and 2 (light 
sleep; min and %) and 3 and 4 (slow wave sleep/deep sleep; min 
and %); rapid eye movement sleep (REM; min and %); and REM 
latency (time between sleep onset and first appearance of REM 
sleep; min).
Subjective Sleep
In line with previous research (78, 79), we measured sleep 
disturbances using the Insomnia Severity Index (ISI) (78). This 
questionnaire is a seven-item screening measure for insomnia 
and an outcome measure for use in treatment research. The 
items, answered on a five-point Likert scale ranging from 0 
(not at all) to 4 (very much), refer in part to the Diagnostic and 
Statistical Manual of Mental Disorders (80) criteria for insomnia 
by assessing difficulty falling asleep, difficulty remaining asleep, 
early morning awakenings, impaired daytime performance, low 
satisfaction with sleep, and worry about sleep. The higher the 
overall score, the more the participant is assumed to suffer from 
insomnia. Cronbach’s α for the present sample was 0.87.
Depressive Symptoms
To assess symptoms of depression, we used the Beck Depression 
Inventory–Fast Screen (BDI-FS) (81). The BDI-FS is a brief self-
report inventory designed to evaluate depression in patients 
with medical illness. It consists of seven items, and every item 
has a set of four possible responses, representing different levels 
of symptom severity (e.g., or sadness: 0 = “I don’t feel sad”; 1 = 
“I feel sad”; 2 = “I’m sad all the time and I can’t snap out of it”; 
3 = “I’m so sad/unhappy, that I can’t stand it”). Higher scores 
reflect a greater severity of depressive symptoms (range: 0–21). 
Cronbach’s α for the present sample was 0.90.
Fatigue
Participants completed the Fatigue Severity Scale (FSS) (82). The 
FSS consists of nine items, and answers are given on seven-point 
rating scales ranging from 1 (not at all) to 7 (definitively/almost 
always), with higher scores reflecting higher levels of fatigue. 
Cronbach’s α for the present sample was 0.91.
Paresthesia
Patients rated their degree of paresthesia on a 10-point visual 
analogue scale ranging from 0 (no sensations at all) to 10 (severe 
sensations) [see also Ref. (67)].
Physical Activity
Physical activity was assessed with the short form of the 
International Physical Activity Questionnaire (IPAQ-SF). The 
IPAQ-SF was developed by a working group initiated by the World 
Health Organization and the Centers for Disease Control and 
Prevention (83). Based on the results from 12 countries, reliability 
and validity of IPAQ are comparable to other self-reported 
measures of physical activity. The IPAQ-SF asks participants 
about time spent in physical activity over the last 7 days. Minutes 
of moderate- and vigorous-intensity activities were calculated for 
the previous week.
Physical Disability; the Expanded 
Disability Status Scale (EDSS)
The Expanded Disability Status Scale (EDSS) was employed by a 
trained neurologist to assess patients’ level of physical disability. 
The EDSS is an internationally accepted and widely used tool 
to provide an objective assessment of the disability levels of 
patients with MS (84, 85). The total score is on a scale from 0 
(no impairment in neurological dimensions) to 10 (death due to 
MS), with increments of 0.5 to 1, and with higher scores reflecting 
higher levels of disability. Meyer-Moock et al. (86) reported 
in their systematic review the high validity and reliability of 
the EDSS. They further concluded that the EDSS is suitable to 
describe clinical status and physical disability and to monitor 
disease progression.
Multiple Sclerosis and Objective SleepSadeghi Bahmani et al.
4 May 2019 | Volume 10 | Article 265Frontiers in Psychiatry | www.frontiersin.org
Cognitive Performance
Two instruments were used to measure cognitive performance, 
the Montreal Cognitive Assessment (MoCA) (87) and the 
Symbol Digit Modality Test (SDMT) (88). To avoid the learning 
effect, parallel versions of each tool were used.
Global Measurement of Cognitive Performance
The MoCA is a screening instrument that allows a global 
cognitive measurement to be made through the assessment 
of a wide range of cognitive functions, such as i) short-term 
memory; ii) executive functions; iii) visuospatial abilities; iv) 
language; v) attention, concentration, and working memory; 
and vi) temporal and spatial orientation. Its extensive 
validation, international recognition, and recommendation 
in various guidelines make the MoCA a useful brief cognitive 
screening tool in both clinical and research contexts (89) (see 
also https://www.mocatest.org). In the present study, we report 
the overall score, with higher scores reflecting better cognitive 
performance.
Attention, Concentration, and Information 
Processing Speed
The Symbol Digit Modality Test (SDMT) (88) is an instrument 
to assess attention, concentration, and information processing 
speed. The test consists of single digits paired with nine abstract 
symbols. Rows of the symbols are arranged pseudo-randomly. 
The patient must state the number that corresponds to each 
symbol. The SDMT can be completed within 5 min, including 
instructions, practice, and testing. Evidence indicating the 
satisfactory psychometric properties of the SDMT has been 
provided in previous research (90).
Exercise Intervention
Regular endurance exercise was undertaken in the course of a 
standardized 3-week inpatient rehabilitation program. Training 
consisted of physiologically defined heart-rate-controlled 
cycling at 60 rpm at the lactate threshold (75% of HRmax or 65% 
of VO2-peak). A training session lasted 30 min, with warm-up 
and cool-down for the first and last 2 min, respectively. A total 
of five training sessions were conducted per week, representing 
standard care at the rehabilitation center. A sport scientist expert 
in exercise interventions for patients with MS supervised the 
intervention sessions.
Regular exercise was performed in addition to the normal 
rehabilitation program that consisted of two physiotherapy 
interventions per day. Physiotherapy consisted of progressive 
resistance training (45 min) and a low-intensity physiotherapeutic 
session (30 min).
Statistical Analysis
Data were analyzed per protocol. Main outcome variables were 
changes in objective and subjective sleep, depression, fatigue, and 
paresthesia. Secondary outcome variables were physical activity 
and cognitive function.
To compare performances at baseline with performances 
at study end (3 weeks later), a series of paired t-tests was 
performed. Pearson’s correlations were computed between 
level of impairment (EDSS score) and sleep, psychological 
functioning, physical activity, and cognitive performance. The 
level of significance was set at α ≤ .05. All statistical analyses 
were performed with SPSS® 25.0 (IBM Corporation, Armonk, 
NY, USA) for Apple® Mac®.
RESULTS
Sample Characteristics
Of the 51 patients enrolled at baseline, 46 completed the study 
(pre/post assessment, and intervention); 5 did not want to 
participate in the second assessment or left the clinic earlier 
than scheduled. The mean age of the sample at baseline was 
50.74 years (SD = 11.28). In total, 78.4% of the participants were 
females. There was no difference in age between females (M = 
51.89; SD = 11.70) and males [M = 46.00; SD = 8.20; t(44) = 1.42, 
p = .16], nor did they differ in EDSS scores [females: M = 5.49, 
SD = 1.11; males: M = 4.89, SD = 1.27; t(44) = 1.41, p = .17]. 
Next, not all participants completed all questionnaires; degrees 
of freedom therefore vary for the different outcomes. EEG values 
were available only for 26 patients (14 patients were not willing to 
participate in the sleep-EEG assessment, and for 6 patients, data 
were not recorded due to technical failures). EEG completers 
did not statistically significantly differ from noncompleters as 
regards age, EDSS, fatigue, paresthesia, cognitive dysfunction (all 
t values < 1.00; p values > .50), physical activity, and gender (χ2 < 
0.5; p > .50).
Objective Sleep
Table 1 reports the descriptive and inferential statistical indices 
of objective sleep parameters.
With regard to sleep continuity, sleep onset latency significantly 
decreased, sleep efficacy improved, and the time of awakenings 
after sleep onset diminished. For all other dimensions of sleep 
continuity (total sleep time, sleep period time, and numbers 
of awakenings after sleep onset), there were no significant 
differences between the baseline and the study end. With regard 
to sleep architecture (stages 1–4 and REM-sleep: min and %), 
there were no significant differences.
Subjective Sleep, Depression, Fatigue, 
and Paresthesia
Table 2 reports the descriptive and inferential statistical indices 
for subjective sleep, depression, fatigue, and paresthesia. These 
statistical indices are not therefore repeated in the text. From 
baseline to the end of the study, subjective sleep (complaints), 
depression, fatigue, and paresthesia decreased significantly.
Subjective Physical Activity
Table 3 reports the descriptive and inferential statistical indices 
for subjective physical activity. From baseline to the study end, 
subjective vigorous and moderate physical activity increased 
significantly.
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Cognitive Performance
Table 3 also provides the descriptive and inferential statistical 
indices for cognitive performance. From baseline to the study 
end, attention, concentration, and information processing speed 
(SDMT), as well as global cognitive performance (MoCA), 
significantly improved.
Correlations Between Degree of 
Impairment (Expanded Disability 
Status Scale Scores) and Objective and 
Subjective Sleep, Depression, Fatigue, 
Paresthesia, Subjective Physical Activity, 
and Cognitive Performances
All correlation coefficients were small (all r values < .15) and 
nonsignificant (all p values > .30). In other words, degree of 
physical impairment (EDSS) was not related to objective or 
subjective sleep, depression, fatigue, paresthesia, subjective 
physical activity, or cognitive performances either at baseline or 
at study end.
DISCUSSION
The key findings of the present study were that in a sample 
of patients with MS, a 3-week exercising program led to 
improvements in both objective and subjective sleep, depression, 
fatigue, paresthesia, and cognitive performance. The pattern 
of the result makes an important contribution to the current 
literature as, to the best of our knowledge, this is the first study 
TABLE 1 | Objective sleep dimensions at baseline and at the study end.
Time points Statistics
Baseline Prior to discharge Paired t test
M (SD) M (SD)
Total sleep time (h:min:s) 6:09:07 (1:21:21) 6:31:44 (1:03:45) t(25) = −1.34, p = .19
Sleep efficiency (%) 75.39 (14.12) 82.66 (11.19) t(25) = −2.15, p = .04
Sleep onset latency (min) 30.82 (15.63) 7.81 (8.09) t(25) = 6.88, p < .01
Sleep period time (h:min:s) 7:27:12 (1:17:22) 7:28:12 (0:58:00) t(25) = −0.07, p = .95
Awakenings after sleep onset (n) 18.58 (12.6) 15.58 (11.86) t(25) = 1.45, p = .16
Wake time after sleep onset (h/min) 1:57:26 (1:08:59) 1:22:30 (1:08:59) t(25) = −2.10, p = .04
REM sleep (h:min:s) 1:09:04 (0:41:38) 1:18:02 (0:39:17) t(25) = −1.26, p = .22
REM sleep (%) 17.95 (9.82) 19.33 (8.91) t(25) = −0.84, p = 41
S1 (h:min:s) 0:32:51 (0:37:01) 0:37:18 (0:46:05) t(25) = −0.53, p = .65
S1 (%) 8.88 (9.63) 9.78 (12.41) t(25) = −0.42, p = .68
S2 (h:min:s) 3:31:22 (1:25:32) 3:24:51 (1:07:21) t(25) = 0.53, p = .65
S2 (%) 54.8 (17.9) 55.12 (18.66) t(25) = −0.15, p = .921
S3 (h:min:s) 0:44:45 (0:58:39) 0:45:13 (1:10:18) t(25) = −0.05, p = .96
S3 (%) 13.21 (15.80) 10.38 (14.79) t(25) = 1.33, p = .19
S4 (h:min:s) 0:16:39 (0:21:43) 0:20:30 (0:24:04) t(25) = −0.96, p = .35
S4 (%) 4.1 (5.16) 4.76 (5.47) t(25) = −0.73, p = .47
Light sleep (h:min:s) 3:59:21 (1:02:13) 3:55:27 (1:07:14) t(25) = 0.30, p = .77
Light sleep (%) 63.59 (14.48) 63.58 (17.96) t(25) = 0.01, p = .99
Deep sleep (h:min:s) 1:08:43 (1:20:54) 1:13:03 (1:34:49) t(25) = −0.38, p = .71
Deep sleep (%) 17.45 (18.90) 16.27 (18.87) t(25) = 0.55, p = .58
S, stage; REM, rapid eye movement; light sleep, Stage 1 + Stage 2; deep sleep, Stage 3 + Stage 4.
TABLE 2 | Descriptive and inferential statistical overview of values for subjective 
sleep, depression, fatigue, and paresthesia at baseline and at the study end.
Time points Statistics
Baseline Study end Paired t test
M (SD) M (SD)
Sleep complaints 
(ISI)
15.18 (5.71) 14.00 (4.59) t(44) = 2.03, p = .048
Depression (BDI 
fast screen) 
2.87 (2.62) 1.85 (2.04) t(45) = 3.48, p = .001
Fatigue (FSS) 42.18 (14.34) 36.11 (15.92) t(43) = 3.29, p = .002
Paresthesia 4.15 (2.90) 3.26 (2.51) t(45) = 2.75, p = .009
ISI, Insomnia Severity Index; BDI, Beck Depression Inventory; FSS, Fatigue 
Severity Scale.
TABLE 3 | Descriptive and inferential statistical overview of values for subjective 
physical activity and cognitive performance at baseline and at the study end.
Time points Statistics
Baseline Study end Paired t tests
M (SD) M (SD)
IPAQ 
moderate
155.00 (229.78) 689.4 (942.58) t(42) = 3.26, p = .01
IPAQ 
vigorous
98.64 (223.98) 559.09 (1,161.41) t(42) = 2.32, p = .03
SDMT 33.81 (10.58) 36.51 (11.56) t(42) = −2.31, p = .03
MoCA sum 26.16 (2.45) 27.15 (2.83) t(40) = −2.60, p = .01
IPAQ, International Physical Activity Questionnaire; MoCA, Montreal Cognitive 
Assessment; SDMT, Symbol Digit Modality Test.
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to show that regular exercising has positive effects on both the 
objective and subjective sleep of MS patients.
Four hypotheses were formulated and these are considered 
in turn.
Following others (51, 52, 54), our first hypotheses was that a 
3-week program of regular exercise would benefit objective sleep, 
and this hypothesis was confirmed. Specifically, sleep efficiency 
improved, sleep onset latency shortened, and the wake time after 
sleep onset decreased; thus, improvements in sleep continuity 
were observed, though we found no significant changes in sleep 
architecture. We believe that these findings add to the current 
literature in an important way as, to the best of our knowledge, 
these effects have not previously been investigated or observed 
among patients with MS.
We also note that, at baseline, indices of sleep quality such as 
sleep efficiency (75.4%) and sleep onset latency (about 31 min) 
had particularly low values. In our opinion, these findings are 
consistent with observations that sleep quality deteriorates with 
the progression of MS (3, 4, 6, 7, 29, 31, 42), while in studies by 
Sadeghi Bahmani and colleagues (20, 21), sleep complaints were 
not found at disease onset or 2 years later.
Our second hypothesis, following Siengsukon et al. (56), 
was that a 3-week program of regular exercise would improve 
subjective sleep, and this was confirmed. These findings therefore 
replicate those from the only previous study of which we are 
aware, that by Siengsukon et al. (56). However, we expanded 
upon their study, in finding significant changes in subjective 
sleep within a 3-week period.
Several studies have shown that physical activity has the 
potential to ameliorate sleep complaints both in healthy 
individuals and in patients with chronic diseases. Of various 
possible explanations, the most plausible are the consequences 
of reduced physical tiredness and rumination and enhanced 
mood in producing improvement in sleep complaints following a 
program of physical activity (51, 53).
Our third hypothesis was that a 3-week program of regular 
exercise would have a positive impact on the symptoms of 
depression, fatigue, and paresthesia of MS patients. This was 
confirmed for all three variables. Similar effects for depression 
have been reported in other studies. For example, Mota-Pereira 
et al. (91) showed that a program of physical activity involving 
regular walking for 12 consecutive weeks reduced symptoms 
of depression in a sample of treatment-resistant patients with 
major depressive disorders. In this respect, several meta-
analyses have concluded that regular physical activity has 
potential benefits with respect to symptoms of depression both 
among patients with mental impairments (92–98) and among 
patients with MS (67). As regards fatigue, our results are 
consistent with findings from previous studies of MS patients 
(24, 57, 99–101), though we add to the current literature in 
demonstrating such improvements within a period of 3 weeks 
of regular exercising.
As regards paresthesia, so far only one study, Razazian 
et al. (67), has focused on improvements with respect to this 
characteristic following an intervention involving physical 
activity intervention. They showed that both a 2-month 
yoga and a 2-month aquatic exercise intervention reduced 
paresthesia in MS patients. A closer inspection of their 
findings reveals these improvements were due to reductions 
in depression.
Our fourth hypothesis was that a 3-week program of regular 
exercise would lead to improvements in cognitive function, and 
this was supported. These results therefore match the conclusions 
of a review by Sandroff et al. (102) analyzing the impact of 
physical activity on cognitive performance in MS patients across 
26 studies. However, these authors also found that not all subtests 
significantly changed over time. Similarly, for results based on 
the MoCA assessment, we found significant effects with respect 
to memory and language, but not executive function, visuospatial 
ability, attention, or abstract thinking. That can be explained in 
terms of the type of cognitive skill, the timing of the intervention, 
the type of intervention, and the severity of the disease. Results 
equivalent to those for MoCA were obtained for SDMT. We 
were able to show first that, as in other studies, SDMT is a very 
precise tool for assessing cognitive performance in patients with 
MS. Second, changes in cognitive function were more related to 
the total score for cognitive performance than to specific skills. 
After all, all cognitive abilities are influenced by other skills, 
and what we need in coping with daily life is more related to the 
overall cognitive ability than to individual cognitive skills. Our 
findings indicate that a 3-week program of regular exercise is 
useful in enhancing general cognition, although the short period 
of this intervention may have been responsible for the lack of 
improvement in every aspect of cognition.
Despite the novelty of the present findings, several limitations 
warrant against their overgeneralization. The main limitation 
of this study is the absence of a control group. Given that the 
exercise program was part of a defined schedule for all patients 
hospitalized at the Valens Rehabilitation Center, including a 
control group without an exercise program was not an option. 
Nevertheless, we believe that the present pattern of results is 
robust, given that changes could be observed across a broad range 
of characteristics (objective and subjective sleep, psychological 
functioning, cognition). Second, it is possible that the pattern of 
results might have arisen because further unassessed variables 
biased two or more dimensions in the same or the opposite 
directions. Third, bias is also possible in the sample as, for 
reasons related to health insurance conditions, not all patients 
with MS are admitted to the rehabilitation center. Fourth, as 
regards depression, we relied on self-reports, while experts’ 
ratings would have further strengthened the present the pattern 
of the results. Fifth, a follow-up study could provide more insight 
into the longer-term effects of such interventions once patients 
have returned home and to their normal working and social 
environments.
CONCLUSIONS
A 3-week exercise program for patients with MS improved both 
objective and subjective sleep, along with improvements in 
psychological functioning and cognitive performance.
Multiple Sclerosis and Objective SleepSadeghi Bahmani et al.
7 May 2019 | Volume 10 | Article 265Frontiers in Psychiatry | www.frontiersin.org
ETHICS STATEMENT
The local ethics committees of Basel (Ethikkommission 
Nordwestschweiz; EKNZ: 2016-01347) and St. Gallen (EKOS; 
Switzerland) approved the study.
AUTHOR CONTRIBUTIONS
Study design: DSB, JK, JB, MP, UP, VS, MG, EHT, and SB. Data 
gathering: DSB, JK, JB, and MP. Statistics: DSB, MG, VS, EHT, and 
SB. Manuscript draft: DSB, JK, JB, MG, EHT, and SB. Approved 
final version: DSB, JK, JB, MP, UP, VS, MG, EHT, and SB.
ACKNOWLEDGMENTS
We thank Marielle Koenig, Vladimir Djurdjevic, and Daryl 
Niedermoser for the EEG analysis. Further, we thank Joao Ulyssea 
for helping us in data gathering, and we thank Edit Caric and 
Raphael Zihlmann for data entry. Finally, we thank Nick Emler 
(University of Surrey, Surrey UK) for proofreading the manuscript.
REFERENCES
 1. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple 
sclerosis. Clin Neurol Neurosurg (2002) 104(3):182–91. doi: 10.1016/S0303-
8467 (02)00036-7
 2. Alghwiri AA, Khalil H, Al-Sharman A, El-Salem K. Depression is a predictor 
for balance in people with multiple sclerosis. Mult Scler Relat Disord (2018) 
24:28–31. doi: 10.1016/j.msard.2018.05.013
 3. Bamer AM, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep 
problems in individuals with multiple sclerosis. Mult Scler (2008) 
14(8):1127–30. doi: 10.1177/1352458508092807
 4. Braley TJ, Boudreau EA. Sleep disorders in multiple sclerosis. Curr Neurol 
Neurosci Rep (2016) 16(5):50. doi: 10.1007/s11910-016-0649-2
 5. Kallweit U, Baumann CR, Harzheim M, Hidalgo H, Pohlau D, Bassetti CL, 
et al. Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically 
relevant association? Mult Scler Int (2013). doi: 10.1155/2013/286581
 6. Veauthier C. Sleep disorders in multiple sclerosis. Review. Curr Neurol 
Neurosci Rep (2015) 15(5):21. doi: 10.1007/s11910-015-0546-0
 7. Veauthier C, Gaede G, Radbruch H, Wernecke KD, Paul F. Poor sleep 
in multiple sclerosis correlates with beck depression inventory values, 
but not with polysomnographic data. Sleep Disord (2016). doi: 10.1155/ 
2016/8378423
 8. Veauthier C, Paul F. Sleep disorders in multiple sclerosis and their relationship 
to fatigue. Sleep Med (2014) 15(1):5–14. doi: 10.1016/j.sleep.2013.08.791
 9. Motl RW, Dlugonski D, Pilutti L, Sandroff B, McAuley E. Premorbid physical 
activity predicts disability progression in relapsing–remitting multiple 
sclerosis. J Neurol Sci (2012) 323(1–2):123–7. doi: 10.1016/j.jns.2012.08.033
 10. Motl RW, Pilutti LA. Is physical exercise a multiple sclerosis disease 
modifying treatment? Expert Rev Neurother (2016) 16(8):951–60. doi: 
10.1080/14737175.2016.1193008
 11. Pilutti LA, Platta ME, Motl RW, Latimer-Cheung AE. The safety of exercise 
training in multiple sclerosis: a systematic review. J Neurol Sci (2014) 343 
(1–2):3–7. doi: 10.1016/j.jns.2014.05.016
 12. Platta ME, Ensari I, Motl RW, Pilutti LA. Effect of exercise training on 
fitness in multiple sclerosis: a meta-analysis. Arch Phys Med Rehabil (2016) 
97(9):1564–72. doi: 10.1016/j.apmr.2016.01.023
 13. Veldhuijzen van Zanten JJ, Pilutti LA, Duda JL, Motl RW. Sedentary 
behaviour in people with multiple sclerosis: is it time to stand up against 
MS? Mult Scler (2016) 22(10):1250–6. doi: 10.1177/1352458516644340
 14. Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive 
changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 
(2006) 245(1–2):41–6. doi: 10.1016/j.jns.2005.08.019
 15. Benedict RH, Zivadinov R. Risk factors for and management of cognitive 
dysfunction in multiple sclerosis. Nat Rev Neurol (2011) 7(6):332–42. doi: 
10.1038/nrneurol.2011.61
 16. Benedict RHB, DeLuca J, Enzinger C, Geurts JJG, Krupp LB, 
Rao SM. Neuropsychology of multiple sclerosis: looking back and moving 
forward. J Int Neuropsychol Soc (2017) 23(9–10):832–42. doi: 10.1017/
S1355617717000959
 17. Sumowski JF, Benedict R, Enzinger C, Filippi M, Geurts JJ, Hamalainen P, et al. 
Cognition in multiple sclerosis: state of the field and priorities for the future. 
Neurology (2018) 90(6):278–88. doi: 10.1212/WNL.0000000000004977
 18. Carta MG, Paribello P, Anastasia A, De Berardis D, Nardi AE, Fornaro M. 
Pharmacological management of depression in patients with multiple 
sclerosis. Expert Opin Pharmacother (2018) 19(14):1533–40. doi: 10.1080/ 
14656566.2018.1516207
 19. Fornaro M, Solmi M, Veronese N, De Berardis D, Buonaguro EF, 
Tomasetti C, et al. The burden of mood-disorder/cerebrovascular disease 
comorbidity: essential neurobiology, psychopharmacology, and physical 
activity interventions. Int Rev Psychiatry (2017) 29(5):425–35. doi: 
10.1080/09540261.2017.1299695
 20. Sadeghi Bahmani D, Gerber M, Kalak N, Lemola S, Clough PJ, Calabrese P, 
et al. Mental toughness, sleep disturbances, and physical activity in patients 
with multiple sclerosis compared to healthy adolescents and young adults. 
Neuropsychiatr Dis Treat (2016) 12:1571–9. doi: 10.2147/NDT.S111208
 21. Sadeghi Bahmani D, Esmaeili L, Shaygannejad V, Gerber M, Kesselring 
J, Lang UE, et al. Stability of mental toughness, sleep disturbances, and 
physical activity in patients with multiple sclerosis (MS)—a longitudinal and 
pilot study. Front Psychiatry (2018) 9:182. doi: 10.3389/fpsyt.2018.00182
 22. Delle Fave A, Bassi M, Allegri B, Cilia S, Falautano M, Goretti B, et al. Beyond 
disease: happiness, goals, and meanings among persons with multiple 
sclerosis and their caregivers. Front Psychol (2017) 8:2216. doi: 10.3389/
fpsyg.2017.02216
 23. Kargiotis O, Paschali A, Messinis L, Papathanasopoulos P. Quality of life in 
multiple sclerosis: effects of current treatment options. Int Rev Psychiatry 
(2010) 22(1):67–82. doi: 10.3109/09540261003589521
 24. Motl RW, McAuley E, Snook EM, Gliottoni RC. Physical activity and quality of 
life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, 
self-efficacy and social support. Psychol Health Med (2009) 14(1):111–24. 
doi: 10.1080/13548500802241902
 25. Salhofer-Polanyi S, Friedrich F, Loffler S, Rommer PS, Gleiss A, Engelmaier R, 
et al. Health-related quality of life in multiple sclerosis: temperament 
outweighs EDSS. BMC Psychiatry (2018) 18(1):143. doi: 10.1186/s12888 
-018-1719-6
 26. Strober LB, Becker A, Randolph JJ. Role of positive lifestyle activities on 
mood, cognition, well-being, and disease characteristics in multiple sclerosis. 
Appl Neuropsychol Adult (2018) 25(4):304–11. doi: 10.1080/23279095.2018. 
1458518
 27. Barzegar M, Badihian S, Mirmosayyeb O, Ashtari F, Jamadi M, Emami S, 
et al. Comparative study of quality of life, anxiety, depression, and fatigue 
among patients with neuromyelitis optica spectrum disorder and multiple 
sclerosis: the first report from Iran. Mult Scler Relat Disord (2018) 22:161–5. 
doi: 10.1016/j.msard.2018.04.009
 28. Braley TJ, Kratz AL, Kaplish N, Chervin RD. Sleep and cognitive function in 
multiple sclerosis. Sleep (2016) 39(8):1525–33. doi: 10.5665/sleep.6012
 29. Hughes AJ, Dunn KM, Chaffee T. Sleep disturbance and cognitive 
dysfunction in multiple sclerosis: a systematic review. Curr Neurol Neurosci 
Rep (2018) 18(1):2. doi: 10.1007/s11910-018-0809-7
 30. Induruwa I, Constantinescu CS, Gran B. Fatigue in multiple sclerosis—a brief 
review. J Neurol Sci (2012) 323(1–2):9–15. doi: 10.1016/j.jns.2012.08.007
 31. Sater RA, Gudesblatt M, Kresa-Reahl K, Brandes DW, Sater PA. The 
relationship between objective parameters of sleep and measures of fatigue, 
depression, and cognition in multiple sclerosis. Mult Scler J Exp Transl Clin 
(2015) 1:1–8. doi: 10.1177/2055217315577828
Multiple Sclerosis and Objective SleepSadeghi Bahmani et al.
8 May 2019 | Volume 10 | Article 265Frontiers in Psychiatry | www.frontiersin.org
 32. Brand S, Kirov R, Kalak N, Gerber M, Puhse U, Lemola S, et al. Perfectionism 
related to self-reported insomnia severity, but not when controlled for stress 
and emotion regulation. Neuropsychiatr Dis Treat (2015) 11:263–71. doi: 
10.2147/NDT.S74905
 33. Brand S, Kirov R, Kalak N, Gerber M, Schmidt NB, Lemola S, et al. Poor 
sleep is related to lower emotional competence among adolescents. Behav 
Sleep Med (2016) 14(6):602–14. doi: 10.1080/15402002.2015.1048450
 34. Kirov R, Brand S, Kolev V, Yordanova J. The sleeping brain and the neural 
basis of emotions. Behav Brain Sci (2012) 35(3):155–6. doi: 10.1017/
S0140525X11001531
 35. Ahrberg K, Dresler M, Niedermaier S, Steiger A, Genzel L. The interaction 
between sleep quality and academic performance. J Psychiatr Res (2012) 
46(12):1618–22. doi: 10.1016/j.jpsychires.2012.09.008
 36. Curcio G, Ferrara M, De Gennaro L. Sleep loss, learning capacity and 
academic performance. Sleep Med Rev (2006) 10(5):323–37. doi: 10.1016/ 
j.smrv.2005.11.001
 37. Becker SP, Dvorsky MR, Holdaway AS, Luebbe AM. Sleep problems and 
suicidal behaviors in college students. J Psychiatr Res (2018) 99:122–8. doi: 
10.1016/j.jpsychires.2018.01.009
 38. Gangwisch JE, Babiss LA, Malaspina D, Turner JB, Zammit GK, Posner K. 
Earlier parental set bedtimes as a protective factor against depression and 
suicidal ideation. Sleep (2010) 33(1):97–106. doi: 10.1093/sleep/33.1.97
 39. Amtmann D, Askew RL, Kim J, Chung H, Ehde DM, Bombardier CH, 
et al. Pain affects depression through anxiety, fatigue, and sleep in multiple 
sclerosis. Rehabil Psychol (2015) 60(1):81–90. doi: 10.1037/rep0000027
 40. Hare CJ, Crangle CJ, Carney CE, Hart T. Insomnia symptoms, subjective 
appraisals, and fatigue: a multiple mediation model. Behav Sleep Med 
(2017)17(3):1–12. doi: 10.1080/15402002.2017.1342167
 41. Brass SD, Duquette P, Proulx-Therrien J, Auerbach S. Sleep disorders in 
patients with multiple sclerosis. Sleep Med Rev (2010) 14(2):121–9. doi: 
10.1016/j.smrv.2009.07.005
 42. Caminero A, Bartolome M. Sleep disturbances in multiple sclerosis. J Neurol 
Sci (2011) 309(1–2):86–91. doi: 10.1016/j.jns.2011.07.015
 43. Fleming WE, Pollak CP. Sleep disorders in multiple sclerosis. Semin Neurol 
(2005) 25(1):64–8. doi: 10.1055/s-2005-867075
 44. Bamer AM, Johnson KL, Amtmann DA, Kraft GH. Beyond fatigue: assessing 
variables associated with sleep problems and use of sleep medications in 
multiple sclerosis. Clin Epidemiol (2010) 2010(2):99–106. doi: 10.2147/
CLEP.S10425
 45. Thelen JM, Lynch SG, Bruce AS, Hancock LM, Bruce JM. Polypharmacy 
in multiple sclerosis: relationship with fatigue, perceived cognition, and 
objective cognitive performance. J Psychosom Res (2014) 76(5):400–4. doi: 
10.1016/j.jpsychores.2014.02.013
 46. Clancy M, Drerup M, Sullivan AB. Outcomes of cognitive–behavioral 
treatment for insomnia on insomnia, depression, and fatigue for individuals 
with multiple sclerosis: a case series. Int J MS Care (2015) 17(6):261–7. doi: 
10.7224/1537-2073.2014-071
 47. Majendie CMA, Dysch L, Carrigan N. Cognitive behavioral therapy for 
insomnia (CBT-I) for an adult with multiple sclerosis. Clin Case Stud (2016) 
16(2):115–31. doi: 10.1177/1534650116674594
 48. Dayapoglu N, Tan M. Evaluation of the effect of progressive relaxation 
exercises on fatigue and sleep quality in patients with multiple sclerosis. 
J Altern Complement Med (2012) 18(10):983–7. doi: 10.1089/acm.2011.0390
 49. Kraft GH. Rehabilitation principles for patients with multiple sclerosis. 
J Spinal Cord Med (1998) 21(2):117–20. doi: 10.1080/10790268.1998.11719518
 50. Lisak D. Overview of symptomatic management of multiple sclerosis. 
J Neurosci Nurs (2001) 33(5):224–30. doi: 10.1097/01376517-200110000-00002
 51. Chennaoui M, Arnal PJ, Sauvet F, Leger D. Sleep and exercise: a reciprocal 
issue? Sleep Med Rev (2015) 20:59–72. doi: 10.1016/j.smrv.2014.06.008
 52. Kalak N, Gerber M, Kirov R, Mikoteit T, Yordanova J, Puhse U, et al. Daily 
morning running for 3 weeks improved sleep and psychological functioning 
in healthy adolescents compared with controls. J Adolesc Health (2012) 
51(6):615–22. doi: 10.1016/j.jadohealth.2012.02.020
 53. Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW. The effects 
of physical activity on sleep: a meta-analytic review. J Behav Med (2015) 
38(3):427–49. doi: 10.1007/s10865-015-9617-6
 54. Lang C, Brand S, Feldmeth AK, Holsboer-Trachsler E, Puhse U, Gerber M. 
Increased self-reported and objectively assessed physical activity predict 
sleep quality among adolescents. Physiol Behav (2013) 120:46–53. doi: 
10.1016/j.physbeh.2013.07.001
 55. Lang C, Kalak N, Brand S, Holsboer-Trachsler E, Puhse U, Gerber M. The 
relationship between physical activity and sleep from mid adolescence to early 
adulthood. A systematic review of methodological approaches and meta-
analysis. Sleep Med Rev (2016) 28:32–45. doi: 10.1016/j.smrv.2015.07.004
 56. Siengsukon CF, Aldughmi M, Kahya M, Bruce J, Lynch S, Ness Norouzinia 
A, et al. Randomized controlled trial of exercise interventions to improve 
sleep quality and daytime sleepiness in individuals with multiple 
sclerosis: a pilot study. Mult Scler J Exp Transl Clin (2016) 2:1–9. 
doi: 10.1177/2055217316680639
 57. Coote S, Uszynski M, Herring MP, Hayes S, Scarrott C, Newell J, et al. 
Effect of exercising at minimum recommendations of the multiple sclerosis 
exercise guideline combined with structured education or attention control 
education—secondary results of the step it up randomised controlled trial. 
BMC Neurol (2017) 17(1):119. doi: 10.1186/s12883-017-0898-y
 58. Ensari I, Adamson BC, Motl RW. Longitudinal association between 
depressive symptoms and walking impairment in people with relapsing–
remitting multiple sclerosis. J Health Psychol (2015) 21(11):2732–41. doi: 
10.1177/1359105315584837
 59. Ensari I, Motl RW, Pilutti LA. Exercise training improves depressive 
symptoms in people with multiple sclerosis: results of a meta-analysis. 
J Psychosom Res (2014) 76(6):465–71. doi: 10.1016/j.jpsychores.2014.03.014
 60. Latimer-Cheung AE, Martin Ginis KA, Hicks AL, Motl RW, Pilutti LA, 
Duggan M, et al. Development of evidence-informed physical activity 
guidelines for adults with multiple sclerosis. Arch Phys Med Rehabil (2013) 
94(9):1829–36.e1827. doi: 10.1016/j.apmr.2013.05.015
 61. Latimer-Cheung AE, Pilutti LA, Hicks AL, Martin Ginis KA, Fenuta AM, 
MacKibbon KA, et al. Effects of exercise training on fitness, mobility, fatigue, 
and health-related quality of life among adults with multiple sclerosis: a 
systematic review to inform guideline development. Arch Phys Med Rehabil 
(2013) 94(9):1800–28.e1803. doi: 10.1016/j.apmr.2013.04.020
 62. Motl RW, Sandroff BM, Kwakkel G, Dalgas U, Feinstein A, Heesen C, et al. 
Exercise in patients with multiple sclerosis. Lancet Neurol (2017) 16(10):848–
56. doi: 10.1016/S1474-4422(17)30281-8
 63. Snook EM, Motl RW. Effect of exercise training on walking mobility in 
multiple sclerosis: a meta-analysis. Neurorehabil Neural Repair (2009) 
23(2):108–16. doi: 10.1177/1545968308320641
 64. De Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, 
et al. Effect of agomelatine treatment on C-reactive protein levels in patients with 
major depressive disorder: an exploratory study in “real-world,” everyday clinical 
practice. CNS Spectr (2017) 22(4):342–7. doi: 10.1017/S1092852916000572
 65. Marini S, Vellante F, Matarazzo I, De Berardis D, Serroni N, Gianfelice D, 
et al. Inflammatory markers and suicidal attempts in depressed patients: 
a review. Int J Immunopathol Pharmacol (2016) 29(4):583–94. doi: 10.1177/ 
0394632015623793
 66. Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives 
on new treatment strategies. Cell Physiol Biochem (2013) 31(6):761–77. doi: 
10.1159/000350094
 67. Razazian N, Yavari Z, Farnia V, Azizi A, Kordavani L, Bahmani DS, et al. 
Exercising impacts on fatigue, depression, and paresthesia in female patients 
with multiple sclerosis. Med Sci Sports Exerc (2016) 48(5):796–803. doi: 
10.1249/MSS.0000000000000834
 68. Brand S, Colledge F, Ludyga S, Emmenegger R, Kalak N, Sadeghi Bahmani 
D, et al. Acute bouts of exercising improved mood, rumination and social 
interaction in inpatients with mental disorders. Front Psychol (2018) 9(249). 
doi: 10.3389/fpsyg.2018.00249
 69. Ludyga S, Gerber M, Brand S, Holsboer-Trachsler E, Puhse U. Acute effects 
of moderate aerobic exercise on specific aspects of executive function in 
different age and fitness groups: a meta-analysis. Psychophysiology (2016) 
53(11):1611–26. doi: 10.1111/psyp.12736
 70. Ludyga S, Gerber M, Mucke M, Brand S, Weber P, Brotzmann M, et al. The 
acute effects of aerobic exercise on cognitive flexibility and task-related heart 
rate variability in children with ADHD and healthy controls. J Atten Disord 
(2018). doi: 10.1177/1087054718757647
 71. Prakash RS, Patterson B, Janssen A, Abduljalil A, Boster A. Physical activity asso-
ciated with increased resting-state functional connectivity in multiple sclerosis. 
J Int Neuropsychol Soc (2011) 17(6):986–97. doi: 10.1017/S1355617711001093
Multiple Sclerosis and Objective SleepSadeghi Bahmani et al.
9 May 2019 | Volume 10 | Article 265Frontiers in Psychiatry | www.frontiersin.org
 72. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. 
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald 
criteria. Ann Neurol (2011) 69(2):292–302. doi: 10.1002/ana.22366
 73. Brand S, Beck J, Gerber M, Hatzinger M, Holsboer-Trachsler E. Evidence of 
favorable sleep-EEG patterns in adolescent male vigorous football players 
compared to controls. World J Biol Psychiatry (2010) 11(2 Pt 2):465–75. doi: 
10.1080/15622970903079820
 74. Brand S, Gerber M, Beck J, Hatzinger M, Puhse U, Holsboer-Trachsler E. 
Exercising, sleep-EEG patterns, and psychological functioning are related 
among adolescents. World J Biol Psychiatry (2010) 11(2):129–40. doi: 
10.3109/15622970903522501
 75. Gerber M, Brand S, Herrmann C, Colledge F, Holsboer-Trachsler E, Puhse U. 
Increased objectively assessed vigorous-intensity exercise is associated with 
reduced stress, increased mental health and good objective and subjective 
sleep in young adults. Physiol Behav (2014) 135:17–24. doi: 10.1016/j.
physbeh.2014.05.047
 76. Gerber M, Colledge F, Puhse U, Holsboer-Trachsler E, Zimmerer S, Brand 
S. Sleep quality, sleep EEG pattern, mental well-being and cortisol secretion 
in patients with ruptured aneurysm post-treatment: a comparison with 
post-surgery meningioma patients and controls. Neuropsychobiology (2016) 
73(3):148–59. doi: 10.1159/000444492
 77. Hornung OP, Regen F, Warnstedt C, Anghelescu I, Danker-Hopfe H, 
Heuser I, et al. Declarative and procedural memory consolidation during 
sleep in patients with borderline personality disorder. J Psychiatr Res (2008) 
42(8):653–8. doi: 10.1016/j.jpsychires.2007.07.001
 78. Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity 
Index as an outcome measure for insomnia research. Sleep Med (2001) 
2(4):297–307. doi: 10.1016/S1389-9457(00)00065-4
 79. Gerber M, Lang C, Lemola S, Colledge F, Kalak N, Holsboer-Trachsler E, 
et al. Validation of the German version of the insomnia severity index 
in adolescents, young adults and adult workers: results from three 
cross-sectional studies. BMC Psychiatry (2016) 16:174. doi: 10.1186/
s12888-016-0876-8
 80. American Psychiatric Association. Diagnostic and statistical manual of 
mental disorders, 5th edition: DSM 5. Arlington VA: American Psychiatric 
Association (2013).
 81. Benedict RH, Fishman I, McClellan MM, Bakshi R, Weinstock-Guttman B. 
Validity of the beck depression inventory-fast screen in multiple sclerosis. 
Mult Scler (2003) 9(4):393–6. doi: 10.1191/1352458503ms902oa
 82. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity 
scale. Application to patients with multiple sclerosis and systemic lupus 
erythematosus. Arch Neurol (1989) 46(10):1121–3. doi: 10.1001/archneur. 
1989.00520460115022
 83. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth 
BE. International physical activity questionnaire: 12-country reliability 
and validity. Med Sci Sports Exerc (2003) 35:1381–95. doi: 10.1249/01.
MSS.0000078924.61453.FB
 84. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded 
disability status scale (EDSS). Neurology (1983) 33(11):1444–52. doi: 
10.1212/WNL.33.11.1444
 85. Kurtzke JF. On the origin of EDSS. Mult Scler Relat Disord (2015) 4(2):95–
103. doi: 10.1016/j.msard.2015.02.003
 86. Meyer-Moock S, Feng YS, Maeurer M, Dippel FW, Kohlmann T. Systematic 
literature review and validity evaluation of the Expanded Disability 
Status Scale (EDSS) and the Multiple Sclerosis Functional Composite 
(MSFC) in patients with multiple sclerosis. BMC Neurol (2014) 14:58. doi: 
10.1186/1471-2377-14-58
 87. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, 
Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening 
tool for mild cognitive impairment. J Am Geriatr Soc (2005) 53(4):695–9. 
doi: 10.1111/j.1532-5415.2005.53221.x
 88. Smith A. Symbol digits modalities test: Manual. Los Angeles: Western 
Psychological Services (1982).
 89. Gauthier S, Patterson C, Gordon M, Soucy JP, Schubert F, Leuzy A. 
Commentary on “Recommendations from the National Institute on 
Aging–Alzheimer’s Association workgroups on diagnostic guidelines for 
Alzheimer’s disease.” A Canadian perspective. Alzheimers Dement (2011) 
7(3):330–2. doi: 10.1016/j.jalz.2011.03.006
 90. Thomann AE, Goettel N, Monsch RJ, Berres M, Jahn T, Steiner LA, et al. 
The montreal cognitive assessment: normative data from a german-speaking 
cohort and comparison with international normative samples. J Alzheimers 
Dis (2018) 64(2):643–55. doi: 10.3233/JAD-180080
 91. Mota-Pereira J, Carvalho S, Silverio J, Fonte D, Pizarro A, Teixeira J, et al. 
Moderate physical exercise and quality of life in patients with treatment-
resistant major depressive disorder. J Psychiatr Res (2011) 45(12):1657–9. 
doi: 10.1016/j.jpsychires.2011.08.008
 92. Bailey AP, Hetrick SE, Rosenbaum S, Purcell R, Parker AG. Treating 
depression with physical activity in adolescents and young adults: a systematic 
review and meta-analysis of randomised controlled trials. Psychol Med (2017) 
48(7):1068–83. doi: 10.1017/S0033291717002653
 93. Josefsson T, Lindwall M, Archer T. Physical exercise intervention in 
depressive disorders: meta-analysis and systematic review. Scand J Med Sci 
Sports (2014) 24(2):259–72. doi: 10.1111/sms.12050
 94. Perez-Lopez FR, Martinez-Dominguez SJ, Lajusticia H, Chedraui P. Effects 
of programmed exercise on depressive symptoms in midlife and older 
women: a meta-analysis of randomized controlled trials. Maturitas (2017) 
106:38–47. doi: 10.1016/j.maturitas.2017.09.001
 95. Poyatos-Leon R, Garcia-Hermoso A, Sanabria-Martinez G, Alvarez-Bueno 
C, Cavero-Redondo I, Martinez-Vizcaino V. Effects of exercise-based 
interventions on postpartum depression: a meta-analysis of randomized 
controlled trials. Birth (2017) 44(3):200–8. doi: 10.1111/birt.12294
 96. Schuch F, Vancampfort D, Firth J, Rosenbaum S, Ward P, Reichert T, et al. 
Physical activity and sedentary behavior in people with major depressive 
disorder: a systematic review and meta-analysis. J Affect Disord (2017) 
210:139–50. doi: 10.1016/j.jad.2016.10.050
 97. Sun M, Lanctot K, Herrmann N, Gallagher D. Exercise for cognitive 
symptoms in depression: a systematic review of interventional studies. Can J 
Psychiatry (2017) 63(2):115–28. doi: 10.1177/0706743717738493
 98. Wu PL, Lee M, Huang TT. Effectiveness of physical activity on patients with 
depression and Parkinson’s disease: a systematic review. PLoS One (2017) 
12(7):e0181515. doi: 10.1371/journal.pone.0181515
 99. Backus D. Increasing physical activity and participation in people with multiple 
sclerosis: a review. Arch Phys Med Rehabil (2016) 97(9 Suppl):S210–17. doi: 
10.1016/j.apmr.2015.09.027
 100. Heine M, van de Port I, Rietberg MB, van Wegen EE, Kwakkel G. Exercise 
therapy for fatigue in multiple sclerosis. Cochrane Database Syst Rev (2015) 
(9):Cd009956. doi: 10.1002/14651858.CD009956.pub2
 101. Waschbisch A, Tallner A, Pfeifer K, Maurer M. Multiple sclerosis and 
exercise: effects of physical activity on the immune system. Nervenarzt 
(2009) 80(6):688–92. doi: 10.1007/s00115-008-2639-3
 102. Sandroff BM, Motl RW, Scudder MR, DeLuca J. Systematic, evidence-based 
review of exercise, physical activity, and physical fitness effects on cognition 
in persons with multiple sclerosis. Neuropsychol Rev (2016) 26(3):271–94. 
doi: 10.1007/s11065-016-9324-2
Conflict of Interest Statement: The authors declare that the research was 
conducted in the absence of any commercial or financial relationships that could 
be construed as a potential conflict of interest.
Copyright © 2019 Sadeghi Bahmani, Kesselring, Papadimitriou, Bansi, Pühse, 
Gerber, Shaygannejad, Holsboer-Trachsler and Brand. This is an open-access article 
distributed under the terms of the Creative Commons Attribution License (CC 
BY). The use, distribution or reproduction in other forums is permitted, provided 
the original author(s) and the copyright owner(s) are credited and that the original 
publication in this journal is cited, in accordance with accepted academic practice. No 
use, distribution or reproduction is permitted which does not comply with these terms.
